SynthesisDiabetes therapy : research, treatment and education of diabetes and related disorders2026

Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.

Jorge Rico-Fontalvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.